STOCK TITAN

NOVONIX Ltd (NVNXF) SEC Filings, Apr-May 2026

NVNXF OTC

Welcome to our dedicated page for NOVONIX SEC filings (Ticker: NVNXF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

NOVONIX Limited filings document foreign-issuer reports furnished on Form 6-K, with exhibits drawn from ASX announcements and corporate notices. The record includes disclosures on annual general meeting presentations and voting results, material-event updates, material agreements, operating and financial results, and governance matters tied to the company's battery materials business.

Capital-structure filings cover applications for quotation of ordinary fully paid securities, securities issued from option exercises or convertible-security conversions, performance rights, and director interest notices. These filings also record shareholder voting matters and formal updates relevant to NOVONIX's ADR and foreign-issuer reporting framework.

Rhea-AI Summary

NOVONIX Ltd director Ronald C. Edmonds reported his holdings of share rights linked to the company’s ordinary shares. The filing shows share rights over 195,938 underlying ordinary shares with an exercise price of $0.00 per share, exercisable from December 31, 2026 and expiring on December 31, 2027. This entry reflects a reported position rather than a new purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

NOVONIX Ltd director Burrow Sharan reported a holding of 195,938 share rights linked to ordinary shares. These rights have a zero exercise price and are scheduled to become exercisable on December 31, 2026, with an expiration date of December 31, 2027. The filing reflects a position update rather than a new buy or sell transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

NOVONIX Ltd director and Chief Executive Officer Michael O'Kronley reported his existing derivative holdings in the form of performance rights. These rights relate to 5,862,567 underlying ordinary shares, have an exercise price of $0.0000, become exercisable on December 31, 2028, and expire on December 31, 2029. The entry is recorded as a holding, with no buy or sell transaction reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Novonix Limited filed a Form 6-K that includes an ASX Appendix 3Y detailing a change in director interests for Michael O’Kronley. The filing records the issue of performance rights to the director following shareholder approval at the AGM held on 15 April 2026.

After this change, Michael O’Kronley holds 9,586,538 performance rights. The notice also confirms that the interests were not traded during a closed period, so no special trading clearance was required.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

NOVONIX Limited reports key strategic and cash developments for the quarter ended 31 March 2026. The U.S. Government certified the company’s Riverside project for a previously allocated US$103 million Section 48C advanced manufacturing tax credit, expected when the first 11,000 tonnes per annum of capacity is placed in service before 7 April 2028, with credits that can be sold to a third party.

NOVONIX signed a binding term sheet to divest its Battery Technology Solutions business while retaining a 15% equity stake, and secured exclusive rights to evaluate buying adjacent Riverside land for US$26.5 million, a move the company says could enable more than US$200 million in potential capital savings if a 50,000 tpa build-out is consolidated on one site. The company also highlighted revised mass production timing for Panasonic Energy to the second half of 2027 and a changing U.S. trade environment for anode materials.

Financially, NOVONIX posted a quarterly operating cash outflow of US$14.4 million and invested US$6.8 million in property, plant, and equipment, mainly at Riverside. Cash and cash equivalents were US$57.1 million at quarter-end, equating to an estimated 4.0 quarters of funding based on recent cash usage. The company also received notice from Nasdaq that its ADRs no longer meet the US$1.00 minimum bid price requirement and is assessing options such as adjusting the ADR-to-ordinary share ratio.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Novonix Limited is reporting the issue and ASX quotation of additional ordinary fully paid shares resulting from the conversion of performance rights under an employee incentive scheme. The new shares are in an existing quoted class and will rank equally with other ordinary shares from their issue date.

No cash is being paid for these shares, with the consideration valued at approximately AUD 0.265 per share. Following this quotation, Novonix states that its quoted ordinary share capital on ASX will comprise 861,442,940 ordinary fully paid shares, alongside several unquoted classes including performance rights, options and convertible notes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

NOVONIX Limited filed an amended Form 6-K to correct formatting in its previously furnished AGM presentation, confirming no substantive changes to the underlying content. The filing also provides the Chairman’s address, updated strategy, and detailed voting results from the April 15, 2026 Annual General Meeting.

The Chairman highlights 2025 as a key year, including delivery of the first mass-production, commercial-grade synthetic graphite sample and installation of four graphitization furnaces at the Riverside facility in Chattanooga to support Panasonic Energy qualification. NOVONIX expects mass production of industrial-grade synthetic graphite to begin in 2026 and now anticipates mass production of battery-grade anode material for Panasonic Energy in the second half of 2027.

The company executed a funding agreement with Yorkville Advisors for access to US$100 million in convertible debentures, sold its Mt Dromedary natural graphite project, and agreed a binding term sheet to divest its Battery Technology Solutions division while retaining 15% ownership. NOVONIX reports contracted offtakes including a four‑year, 10,000‑tonne commitment and a five‑year, minimum 32,000‑tonne commitment, both subject to successful qualification. All AGM resolutions, including director re‑elections, performance rights, share rights, and additional 10% placement capacity, were carried by strong majorities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

NOVONIX Limited has reported the issue of new shares on the ASX following the conversion of performance rights under an employee incentive scheme. The company will have 861,410,374 ordinary fully paid shares quoted on ASX after the quotation of 13,442 additional shares issued on April 17, 2026.

The new shares are issued for non-cash consideration linked to performance rights valued at approximately AUD 0.295 per share. NOVONIX also has unquoted performance rights, options with various expiries and prices, and convertible notes on issue in addition to its quoted share capital.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

NOVONIX Limited provides an update from its Annual General Meeting, outlining progress toward large-scale U.S. synthetic graphite production and confirming all AGM resolutions passed by poll. The company has installed four graphitization furnaces at its Chattanooga Riverside facility and delivered its first mass production, commercial-grade synthetic graphite sample for industrial uses in 2025. NOVONIX expects mass production of industrial-grade synthetic graphite to start in 2026 and now anticipates mass production of battery-grade anode material for Panasonic Energy in the second half of 2027, following rigorous qualification processes. It has invested about $200 million in Chattanooga operations and is planning expansion to 50,000 tonnes per annum, with potential capital savings of more than $200 million if capacity is consolidated on one site. Funding support includes a $100 million convertible debenture facility with Yorkville Advisors, a $100 million CMEI grant for Riverside, and a $754 million conditionally committed DOE loan to support future capacity. NOVONIX holds binding offtake commitments totaling 10,000 tonnes over four years and at least 32,000 tonnes over five years, subject to product qualification, and continues discussions with additional customers while also divesting non-core assets to focus on U.S. synthetic graphite.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

NOVONIX Limited reports that the U.S. Government has certified its Riverside synthetic graphite project for US$103 million in Section 48C Advanced Energy Project tax credits. NOVONIX will receive these credits once its first 11,000 tpa of production is placed in service before 7 April 2028. The credits are transferable and can be sold to a third party, supporting the company’s plan to build a domestic synthetic graphite supply chain from its Chattanooga, Tennessee operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

How many NOVONIX (NVNXF) SEC filings are available on StockTitan?

StockTitan tracks 99 SEC filings for NOVONIX (NVNXF), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for NOVONIX (NVNXF)?

The most recent SEC filing for NOVONIX (NVNXF) was filed on May 6, 2026.